Finance

Lists
B43:FRA
First Tracks Biotherapeutics Inc
€39.95
-1.36%
(-0.55) 1D
Nov 20, 10:00:00 PM GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for B43...
Open
€39.95
High
€39.95
Low
€39.95
Mkt. cap
1.75B
Avg. vol.
33.00
Volume
0.00
52-wk high
€46.50
52-wk low
€27.00
No. of employees
104
Open
€39.95
High
€39.95
Low
€39.95
Mkt. cap
1.75B
Avg. vol.
33.00
Volume
0.00
52-wk high
€46.50
52-wk low
€27.00
No. of employees
104
News stories
From web sources and news partners
About First Tracks Biotherapeutics Inc
CEO-
Employees104
Founded2019
Headquarters-
SectorHealth Care
IndustryBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
33.32M
33.96M
25.64M
23.85M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.74M
18.86M
9.29M
9.00M
Operating expense
45.06M
52.81M
34.94M
32.84M
Total operating expenses
45.06M
52.81M
34.94M
32.84M
Operating income
-45.06M
-52.81M
-34.94M
-32.84M
Other non operating income
-
-1.00K
-1.00K
-7.00K
EBT including unusual items
-41.86M
-50.48M
-33.37M
-31.36M
EBT excluding unusual items
-41.86M
-50.48M
-33.37M
-31.36M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-41.86M
-50.48M
-33.37M
-31.36M
Net profit margin
-
-
-
-
Earnings per share
-
-
-0.95
-0.88
Interest and investment income
3.20M
2.33M
1.56M
1.50M
Interest expense
-
-
-
-
Net interest expenses
3.20M
2.33M
1.56M
1.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
-44.92M
-52.69M
-34.83M
-32.75M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps